Tenecteplase in Acute Ischemic Stroke
Pharmacy to Dose: The Critical Care Podcast
The Role of Connective Place in Thrombolysis
If these are positive trials, they're absolutely going to be trying to figure out how they can get more patients to receive thrombolysis and things. One of the biggest adverse effects we're trying to prevent is a symptomatic intracranial hemorrhage. Do we know if one agent has a higher rate of this adverse effect than another thinking about these agents? So I don't have a very good answer as of now.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
